Canopy Growth Corp
NASDAQ:CGC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Canopy Growth Corp
NASDAQ:CGC
|
CA |
|
T
|
Travelers Companies Inc
F:PA9
|
US |
|
W
|
Wal Mart de Mexico SAB de CV
SWB:4GNB
|
MX |
|
Vaudoise Assurances Holding SA
OTC:VDASF
|
CH |
|
Pliant Therapeutics Inc
NASDAQ:PLRX
|
US |
|
X
|
Xtb SA
WSE:XTB
|
PL |
|
F
|
Fiserv Inc
F:FIV
|
US |
|
B
|
Becton Dickinson and Co
SWB:BOX
|
US |
|
A
|
AstraZeneca PLC
STO:AZN
|
UK |
|
S
|
SF Real Estate Investment Trust
HKEX:2191
|
HK |
|
R
|
Relx PLC
SWB:RDEB
|
UK |
|
Carter Bank and Trust
NASDAQ:CARE
|
US |
|
D
|
Dechra Pharmaceuticals PLC
SWB:1PK
|
UK |
Bankruptcy Probability
Canopy Growth Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Canopy Growth Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Canopy Growth Corp
TSX:WEED
|
706.6m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
894.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
532.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
207B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
275.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Canopy Growth Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Canopy Growth Corp has total debt of 242.3m CAD. This includes both short-term (0 CAD) and long-term (242.3m CAD) debt.
You can find a full breakdown on its Balance Sheet.
